Have a personal or library account? Click to login
When to measure plasma homocysteine and how to place it in context: The homocystinurias Cover

When to measure plasma homocysteine and how to place it in context: The homocystinurias

By: Martina Huemer  
Open Access
|Oct 2020

Figures & Tables

Figure 1

Simplified methionine-homocysteine pathway. AdoMet, S-adenosylmethionine; AdoHcy, S-adenosylhomocysteine; MTHFR, 5,10 methylenetetrahydrofolate reductase; MS, methionine synthase; CH3-Cbl, methylcobalamin; GNMT, glycine N-methyltransferase ; CBS, cystathionine β-synthase; MAT I/III, methionine adenosyltransferase.* methyl group transfer
Simplified methionine-homocysteine pathway. AdoMet, S-adenosylmethionine; AdoHcy, S-adenosylhomocysteine; MTHFR, 5,10 methylenetetrahydrofolate reductase; MS, methionine synthase; CH3-Cbl, methylcobalamin; GNMT, glycine N-methyltransferase ; CBS, cystathionine β-synthase; MAT I/III, methionine adenosyltransferase.* methyl group transfer

Figure 2

Simplified overview of the intracellular processing of Cbl and its intracellular metabolites adenosyl-Cbl and methyl-Cbl. In cblF and cblJ disease, liberation of Cbl from the lysosome and processing to the MMACHC gene product (cblC), which decyanides Cbl, fails. Depending on the locus of the mutation in the MMACHD gene, cblD disease may either affect the synthesis of both adenosyl-and methyl-Cbl or of only one of the pathways. Adenosyl-Cbl is the cofactor for intramitochondrial MMA metabolism by mutase and the cblA and cblB proteins. Methyl-Cbl is cofactor for the remethylation of Hcy to Met by MS (CblG) and MSR (cblE).*Main disorders in this pathway are gastric intrinsic factor deficiency (GIF), Imerslund Graesbeck syndrome (AMN; CUBN) and transcobalamin deficiency (TCN2).
Simplified overview of the intracellular processing of Cbl and its intracellular metabolites adenosyl-Cbl and methyl-Cbl. In cblF and cblJ disease, liberation of Cbl from the lysosome and processing to the MMACHC gene product (cblC), which decyanides Cbl, fails. Depending on the locus of the mutation in the MMACHD gene, cblD disease may either affect the synthesis of both adenosyl-and methyl-Cbl or of only one of the pathways. Adenosyl-Cbl is the cofactor for intramitochondrial MMA metabolism by mutase and the cblA and cblB proteins. Methyl-Cbl is cofactor for the remethylation of Hcy to Met by MS (CblG) and MSR (cblE).*Main disorders in this pathway are gastric intrinsic factor deficiency (GIF), Imerslund Graesbeck syndrome (AMN; CUBN) and transcobalamin deficiency (TCN2).

Figure 3

Diagnostic algorithm for patients with elevated tHcy. Dotted arrows indicate investigations that may be helpful but are not confirmatory. +Parameters do not correspond with the biochemical phenotype and are expected to be normal but may be low for unrelated reasons. *low Cbl has been observed in some patients with combined remethylation disorders for unclear reasons
Diagnostic algorithm for patients with elevated tHcy. Dotted arrows indicate investigations that may be helpful but are not confirmatory. +Parameters do not correspond with the biochemical phenotype and are expected to be normal but may be low for unrelated reasons. *low Cbl has been observed in some patients with combined remethylation disorders for unclear reasons

Symptoms at disease presentation by age in remethylation disorders (a) and CBS deficiency (b) in estimated order of frequency_ There is wide range of ages at presentation and spectrum of severity, from asymptomatic individuals to severely affected patients with multi-system disease_

(a) Remethylation disorders
Early onset (<12 months)
Feeding difficulties / failure to thrive
Muscular hypotonia
Developmental / cognitive impairment
Seizures
Eye disease (nystagmus, visual impairment)

The typical eye disease observed in Cbl-related remethylation disorders is generally limited to early onset forms and not present in MTHFR deficiency.

Hydrocephalus
Acute metabolic decompensation
Cardiac disease (cardiac malformation; cardiomyopathy
Atypical haemolytic uraemic syndrome
Behavioural problems
Movement disorders
Stroke / thromboembolic event
Anaemia/thrombocytopenia or pancytopenia, megaloblastosis
Chronic renal failure
Pulmonary hypertension
Late onset (>12 months)
Failure to thrive / weight loss / feeding problems
Developmental / cognitive impairment
Seizures
Muscular hypotonia / muscle weakness
Thromboembolism / stroke / pulmonary embolism
Psychiatric disease
Movement disorder
Myelopathy
Atypical haemolytic uraemic syndrome
Acute metabolic decompensation
Chronic renal failure
Cardiac disease
[5, 9, 10, 14]
(b) CBS deficiency (classical homocystinuria)

Clinical manifestations are generally more severe in pyridoxine non-responsive disease.

Ectopia lentis and/or severe myopia
Developmental delay/intellectual disability
Thromboembolic events
Excessive height and length of the limbs (‘marfanoid’ habitus)
Osteoporosis and bone deformities (pectus excavatum or carinatum, genu
valgum, scoliosis)
Seizures, psychiatric and behavioural problems and extrapyramidal signs
[3,4, 15,32]

Inborn errors and acquired conditions associated with elevated tHcy in blood

GeneMIM codeMMACbl

high methionine;

CBS deficiency (classical homocystinuria)
CBS 21q22.3236200n

Cbl is expected to be normal (but may be affected by acquired conditions such as decreased su pply). In haptocorrin deficiency, transcobalamin receptor deficiency, MTHFD1 deficiency, and the X-chromosomally inherited HCFC1 defect, tHcy may be but is not consistently elevated. In hypermethioninemias caused by MAT I/III, GNMT, SAHH or ADK deficiencies, tHcy is usually normal or only mildly elevated (usually below 50 μmol/L ) [6, 19, 20].

Acquired conditions resulting in decreased cobalamin supply / absorption

low or normal methionine;

Nutritional Cbl deficiency including neonatal due to maternal Cbl deficiency
--

low or normal methionine;

IF / gastric parietal cell antibodies
--

low or normal methionine;

Gastric intrinsic factor deficiency
GIF 11q12.1261000often ↓
Inborn errors of cobalamin absorption

low or normal methionine;

Imerslund-Gräsbeck syndrome
AMN 14q32.32 CUBN 10p13261100often ↓

low or normal methionine;

Transcobalamin deficiency
TCN2 22q12.2275350

Cbl is expected to be normal (but may be affected by acquired conditions such as decreased su pply). In haptocorrin deficiency, transcobalamin receptor deficiency, MTHFD1 deficiency, and the X-chromosomally inherited HCFC1 defect, tHcy may be but is not consistently elevated. In hypermethioninemias caused by MAT I/III, GNMT, SAHH or ADK deficiencies, tHcy is usually normal or only mildly elevated (usually below 50 μmol/L ) [6, 19, 20].

Combined inborn errors of remethylation

low or normal methionine;

cblF defect
LMBRD1 6q13277380

Cbl is expected to be normal (but may be affected by acquired conditions such as decreased su pply). In haptocorrin deficiency, transcobalamin receptor deficiency, MTHFD1 deficiency, and the X-chromosomally inherited HCFC1 defect, tHcy may be but is not consistently elevated. In hypermethioninemias caused by MAT I/III, GNMT, SAHH or ADK deficiencies, tHcy is usually normal or only mildly elevated (usually below 50 μmol/L ) [6, 19, 20].

low or normal methionine;

cblJ defect
ABCD4 14q24.3614857

Cbl is expected to be normal (but may be affected by acquired conditions such as decreased su pply). In haptocorrin deficiency, transcobalamin receptor deficiency, MTHFD1 deficiency, and the X-chromosomally inherited HCFC1 defect, tHcy may be but is not consistently elevated. In hypermethioninemias caused by MAT I/III, GNMT, SAHH or ADK deficiencies, tHcy is usually normal or only mildly elevated (usually below 50 μmol/L ) [6, 19, 20].

low or normal methionine;

cblC defect
MMACHC 1p34.1277400

Cbl is expected to be normal (but may be affected by acquired conditions such as decreased su pply). In haptocorrin deficiency, transcobalamin receptor deficiency, MTHFD1 deficiency, and the X-chromosomally inherited HCFC1 defect, tHcy may be but is not consistently elevated. In hypermethioninemias caused by MAT I/III, GNMT, SAHH or ADK deficiencies, tHcy is usually normal or only mildly elevated (usually below 50 μmol/L ) [6, 19, 20].

low or normal methionine;

cblD-MMAHcy defect
MMADHC 2q23.2277410

Cbl is expected to be normal (but may be affected by acquired conditions such as decreased su pply). In haptocorrin deficiency, transcobalamin receptor deficiency, MTHFD1 deficiency, and the X-chromosomally inherited HCFC1 defect, tHcy may be but is not consistently elevated. In hypermethioninemias caused by MAT I/III, GNMT, SAHH or ADK deficiencies, tHcy is usually normal or only mildly elevated (usually below 50 μmol/L ) [6, 19, 20].

Isolated inborn errors of remethylation

low or normal methionine;

cblD-Hcy defect
MMADHC 2q23.2277410n

Cbl is expected to be normal (but may be affected by acquired conditions such as decreased su pply). In haptocorrin deficiency, transcobalamin receptor deficiency, MTHFD1 deficiency, and the X-chromosomally inherited HCFC1 defect, tHcy may be but is not consistently elevated. In hypermethioninemias caused by MAT I/III, GNMT, SAHH or ADK deficiencies, tHcy is usually normal or only mildly elevated (usually below 50 μmol/L ) [6, 19, 20].

low or normal methionine;

cblE defect
MTRR 5p15.31236270n

Cbl is expected to be normal (but may be affected by acquired conditions such as decreased su pply). In haptocorrin deficiency, transcobalamin receptor deficiency, MTHFD1 deficiency, and the X-chromosomally inherited HCFC1 defect, tHcy may be but is not consistently elevated. In hypermethioninemias caused by MAT I/III, GNMT, SAHH or ADK deficiencies, tHcy is usually normal or only mildly elevated (usually below 50 μmol/L ) [6, 19, 20].

low or normal methionine;

cblG defect
MTR 1q43250940n

Cbl is expected to be normal (but may be affected by acquired conditions such as decreased su pply). In haptocorrin deficiency, transcobalamin receptor deficiency, MTHFD1 deficiency, and the X-chromosomally inherited HCFC1 defect, tHcy may be but is not consistently elevated. In hypermethioninemias caused by MAT I/III, GNMT, SAHH or ADK deficiencies, tHcy is usually normal or only mildly elevated (usually below 50 μmol/L ) [6, 19, 20].

low or normal methionine;

MTHFR deficiency
MTHFR 1p36.22236250n

Cbl is expected to be normal (but may be affected by acquired conditions such as decreased su pply). In haptocorrin deficiency, transcobalamin receptor deficiency, MTHFD1 deficiency, and the X-chromosomally inherited HCFC1 defect, tHcy may be but is not consistently elevated. In hypermethioninemias caused by MAT I/III, GNMT, SAHH or ADK deficiencies, tHcy is usually normal or only mildly elevated (usually below 50 μmol/L ) [6, 19, 20].

DOI: https://doi.org/10.34763/jmotherandchild.20202402si.2016.000007 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488
Language: English
Page range: 39 - 46
Published on: Oct 2, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Martina Huemer, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.